Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
The 2019 ERS/ESTS/EACTS/ESTRO Guidelines on the Management of Patients With Malignant Pleural Mesothelioma.

Journal of cardiothoracic and vascular anesthesia

Gelzinis TA.
PMID: 32798169
J Cardiothorac Vasc Anesth. 2021 Feb;35(2):378-388. doi: 10.1053/j.jvca.2020.07.017. Epub 2020 Jul 30.

Malignant pleural mesothelioma is a rare aggressive cancer, with insidious growth, and is associated with poor outcomes that have not improved over the years. A task force made up of members of the European Respiratory Society (ERS)/European Society of...

Cite
Gelzinis TA. The 2019 ERS/ESTS/EACTS/ESTRO Guidelines on the Management of Patients With Malignant Pleural Mesothelioma. J Cardiothorac Vasc Anesth. 2020;35(2):378-388doi: 10.1053/j.jvca.2020.07.017.
Gelzinis, T. A. (2021). The 2019 ERS/ESTS/EACTS/ESTRO Guidelines on the Management of Patients With Malignant Pleural Mesothelioma. Journal of cardiothoracic and vascular anesthesia, 35(2), 378-388. https://doi.org/10.1053/j.jvca.2020.07.017
Gelzinis, Theresa A. "The 2019 ERS/ESTS/EACTS/ESTRO Guidelines on the Management of Patients With Malignant Pleural Mesothelioma." Journal of cardiothoracic and vascular anesthesia vol. 35,2 (2021): 378-388. doi: https://doi.org/10.1053/j.jvca.2020.07.017
Gelzinis TA. The 2019 ERS/ESTS/EACTS/ESTRO Guidelines on the Management of Patients With Malignant Pleural Mesothelioma. J Cardiothorac Vasc Anesth. 2021 Feb;35(2):378-388. doi: 10.1053/j.jvca.2020.07.017. Epub 2020 Jul 30. PMID: 32798169.
Copy Download .nbib Format: NLM
Identification of genes and pathways involved in malignant pleural mesothelioma using bioinformatics methods.

BMC medical genomics

Liu X, Qian K, Lu G, Chen P, Zhang Y.
PMID: 33849532
BMC Med Genomics. 2021 Apr 13;14(1):104. doi: 10.1186/s12920-021-00954-7.

BACKGROUND: Malignant pleural mesothelioma (MPM) is a rare tumor in the pleura. This study was carried out to identify key genes and pathways that may be involved in MPM.METHODS: Microarray datasets GSE51024 and GSE2549 were analyzed for differentially expressed...

Cite
Liu X, Qian K, Lu G, et al. Identification of genes and pathways involved in malignant pleural mesothelioma using bioinformatics methods. BMC Med Genomics. 2021;14(1):104doi: 10.1186/s12920-021-00954-7.
Liu, X., Qian, K., Lu, G., Chen, P., & Zhang, Y. (2021). Identification of genes and pathways involved in malignant pleural mesothelioma using bioinformatics methods. BMC medical genomics, 14(1), 104. https://doi.org/10.1186/s12920-021-00954-7
Liu, Xingsheng, et al. "Identification of genes and pathways involved in malignant pleural mesothelioma using bioinformatics methods." BMC medical genomics vol. 14,1 (2021): 104. doi: https://doi.org/10.1186/s12920-021-00954-7
Liu X, Qian K, Lu G, Chen P, Zhang Y. Identification of genes and pathways involved in malignant pleural mesothelioma using bioinformatics methods. BMC Med Genomics. 2021 Apr 13;14(1):104. doi: 10.1186/s12920-021-00954-7. PMID: 33849532; PMCID: PMC8045401.
Copy Download .nbib Format: NLM
SMART: logical radiotherapy and surgery beyond MARS.

The Lancet. Oncology

Pass HI.
PMID: 33450183
Lancet Oncol. 2021 Feb;22(2):156-157. doi: 10.1016/S1470-2045(20)30672-0. Epub 2021 Jan 12.

No abstract available.

Cite
Pass HI. SMART: logical radiotherapy and surgery beyond MARS. Lancet Oncol. 2021;22(2):156-157doi: 10.1016/S1470-2045(20)30672-0.
Pass, H. I. (2021). SMART: logical radiotherapy and surgery beyond MARS. The Lancet. Oncology, 22(2), 156-157. https://doi.org/10.1016/S1470-2045(20)30672-0
Pass, Harvey I. "SMART: logical radiotherapy and surgery beyond MARS." The Lancet. Oncology vol. 22,2 (2021): 156-157. doi: https://doi.org/10.1016/S1470-2045(20)30672-0
Pass HI. SMART: logical radiotherapy and surgery beyond MARS. Lancet Oncol. 2021 Feb;22(2):156-157. doi: 10.1016/S1470-2045(20)30672-0. Epub 2021 Jan 12. PMID: 33450183.
Copy Download .nbib Format: NLM
What are the psychological effects of mesothelioma on patients and their carers? A scoping review.

Psycho-oncology

Sherborne V, Seymour J, Taylor B, Tod A.
PMID: 32596966
Psychooncology. 2020 Oct;29(10):1464-1473. doi: 10.1002/pon.5454. Epub 2020 Jul 13.

OBJECTIVE: Despite recent advances in research, malignant mesothelioma remains an incurable and devastating disease, typically bringing shock and emotional distress to patients and carers. Little research has addressed the psychological impact on either group. This scoping review examines the...

Cite
Sherborne V, Seymour J, Taylor B, et al. What are the psychological effects of mesothelioma on patients and their carers? A scoping review. Psychooncology. 2020;29(10):1464-1473doi: 10.1002/pon.5454.
Sherborne, V., Seymour, J., Taylor, B., & Tod, A. (2020). What are the psychological effects of mesothelioma on patients and their carers? A scoping review. Psycho-oncology, 29(10), 1464-1473. https://doi.org/10.1002/pon.5454
Sherborne, Virginia, et al. "What are the psychological effects of mesothelioma on patients and their carers? A scoping review." Psycho-oncology vol. 29,10 (2020): 1464-1473. doi: https://doi.org/10.1002/pon.5454
Sherborne V, Seymour J, Taylor B, Tod A. What are the psychological effects of mesothelioma on patients and their carers? A scoping review. Psychooncology. 2020 Oct;29(10):1464-1473. doi: 10.1002/pon.5454. Epub 2020 Jul 13. PMID: 32596966.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries